2002
Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus
Arora S, Yang JM, Craft J, Hait W. Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus. Biochemical And Biophysical Research Communications 2002, 293: 1073-1076. PMID: 12051769, DOI: 10.1016/s0006-291x(02)00324-8.Peer-Reviewed Original ResearchConceptsEEF-2KProtein kinaseSerine/threonine protein kinaseCalmodulin-dependent protein kinase IIIElongation factor 2 kinaseEukaryotic protein kinasesProtein translation apparatusProtein kinase IIIC. elegans enzymeThreonine protein kinaseAmino acid sequenceCell surface receptorsIntact enzyme activityTranslation apparatusKinase IIICellular proteinsCell divisionHigh-specificity antibodiesAcid sequenceHuman enzymeStructural domainsKinaseHuman cancersSurface receptorsEnzyme activity
1997
The transcriptional activator Sp1, a novel autoantigen
Spain T, Sun R, Gradzka M, Lin S, Craft J, Miller G. The transcriptional activator Sp1, a novel autoantigen. Arthritis & Rheumatism 1997, 40: 1085-1095. PMID: 9182919, DOI: 10.1002/art.1780400613.Peer-Reviewed Original ResearchConceptsTranscriptional activator Sp1Novel autoantigenComplex of DNAGC-rich sequencesActivator Sp1Undifferentiated connective tissue diseaseSp1 proteinTranscription activatorConnective tissue diseaseExtractable nuclear antigensEpstein-Barr virusSp1Nuclear extractsCellular DNAMalar rashAntinuclear antibodiesClinical characteristicsProteinDNARaynaud's phenomenonTissue diseaseAutoantigenic proteinsAutoimmune seraElectrophoretic mobilityAutoantigensRevisiting autoantibody profiles in systemic lupus erythematosus.
Olhoffer IH, Peng SL, Craft J. Revisiting autoantibody profiles in systemic lupus erythematosus. The Journal Of Rheumatology 1997, 24: 297-302. PMID: 9034986.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusImmune dysregulationLupus erythematosusAutoantibody profileAutoimmune responseAutoantibody specificitiesU1-RNPGlobal immune dysregulationAutoantibody-positive patientsSoluble autoantigensUbiquitous autoantigensPositive patientsIndividual patientsRetrospective analysisPatientsErythematosusAutoantibodiesAutoantigensDysregulationSpecificityBroad spectrumAutoimmunityDefinitive assayPrevalence
1996
Anti-U5 Small Nuclear Ribonucleoprotein (snRNP) Antibodies: A Rare Anti-U snRNP Specificity
Okano Y, Targoff I, Oddis C, Fujii T, Kuwana M, Tsuzaka K, Hirakata M, Mimori T, Craft J, Medsger T. Anti-U5 Small Nuclear Ribonucleoprotein (snRNP) Antibodies: A Rare Anti-U snRNP Specificity. Clinical Immunology 1996, 81: 41-47. PMID: 8808640, DOI: 10.1006/clin.1996.0155.Peer-Reviewed Original Research
1993
Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III.
Hirakata M, Okano Y, Pati U, Suwa A, Medsger TA, Hardin JA, Craft J. Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III. Journal Of Clinical Investigation 1993, 91: 2665-2672. PMID: 8390487, PMCID: PMC443330, DOI: 10.1172/jci116505.Peer-Reviewed Original ResearchConceptsSystemic sclerosisII antibodiesAnti-RNA polymerase II antibodiesLimited cutaneous diseaseConnective tissue diseaseIdentification of autoantibodiesSera of patientsIndirect immunofluorescence studiesHuman serumTissue diseaseCutaneous diseaseNormal controlsAutoantibodiesSclerosisPatientsHuman antibodiesRNA polymerase IIClinical perspectiveMonoclonal antibodiesAntibodiesSerumRNA polymerase IImmunofluorescence studiesImmunodepletion studiesFurther studies
1992
Autoantigenic epitopes of the b polypeptide of SM small nuclear RNP particles
Ohosone Y, Mimori T, Fujii T, Akizuki M, Matsuoka Y, Irimajiri S, Hardin J, Craft J, Homma M. Autoantigenic epitopes of the b polypeptide of SM small nuclear RNP particles. Arthritis & Rheumatism 1992, 35: 960-966. PMID: 1379432, DOI: 10.1002/art.1780350818.Peer-Reviewed Original ResearchANTIBODIES TO snRNPs IN SYSTEMIC LUPUS ERYTHEMATOSUS
Craft J. ANTIBODIES TO snRNPs IN SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatic Disease Clinics Of North America 1992, 18: 311-335. PMID: 1626072, DOI: 10.1016/s0889-857x(21)00730-4.Peer-Reviewed Original ResearchMeSH KeywordsAntibodiesHumansLupus Erythematosus, SystemicPrecipitin TestsRibonucleoproteinsRNA, Small NuclearAutoantibodies to small nuclear and cytoplasmic ribonucleoproteins in japanese patients with inflammatory muscle disease
Hirakata M, Mimori T, Akizuki M, Craft J, Hardin J, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in japanese patients with inflammatory muscle disease. Arthritis & Rheumatism 1992, 35: 449-456. PMID: 1567494, DOI: 10.1002/art.1780350415.Peer-Reviewed Original ResearchConceptsInflammatory muscle diseaseJapanese patientsChronic interstitial lung diseaseMuscle diseaseAnti-PM/SclDifferent etiologic mechanismsTRNA synthetase antibodiesDistinct clinical subsetInterstitial lung diseasePM/DMControl patientsImmunogenetic backgroundOverlap syndromeClinical subsetsRheumatic diseasesSevere myositisAutoimmune responseRNP antibodiesAutoantibody specificitiesLung diseaseClinical correlationClinical significanceClinical comparisonSynthetase antibodiesEtiologic mechanisms
1990
The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays
Kipnis R, Craft J, Hardin J. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis & Rheumatism 1990, 33: 1431-1437. PMID: 2403405, DOI: 10.1002/art.1780330917.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, AntinuclearAntibody SpecificityFemaleHumansMalePrecipitin TestsRadioimmunoassayScleroderma, SystemicConceptsCommon antibody specificitiesPrimary Raynaud's phenomenonScleroderma overlap syndromeOverlap syndromeDiffuse sclerodermaRaynaud's phenomenonRNP antibodiesCREST syndromeAntinucleolar autoantibodiesAmerican patientsRadioimmunoprecipitation assaysAutoantibodiesIndirect immunofluorescenceSclerodermaAntibody specificityNucleolar antigensPatientsSyndromeAntibodiesImmunoprecipitation assaysAssaysHuman Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide.
Boire G, Craft J. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. Journal Of Clinical Investigation 1990, 85: 1182-1190. PMID: 1690756, PMCID: PMC296550, DOI: 10.1172/jci114551.Peer-Reviewed Original ResearchConceptsHY4 RNAStable associationNative structurePossible functional associationRo RNPsCultured HeLa cellsRNA componentHY5 RNAFunctional associationHeLa cellsPolypeptideLa RNPsRNARNPHuman RoDiscrete subpopulationsMacromolecular targetsPotential macromolecular targetsRelated diseasesRNPsRibonucleoproteinHY1Characteristic physicochemical propertiesStable componentHY3
1989
Biochemical and immunological heterogeneity of the Ro ribonucleoprotein particles. Analysis with sera specific for the RohY5 particle.
Boire G, Craft J. Biochemical and immunological heterogeneity of the Ro ribonucleoprotein particles. Analysis with sera specific for the RohY5 particle. Journal Of Clinical Investigation 1989, 84: 270-279. PMID: 2472427, PMCID: PMC303979, DOI: 10.1172/jci114150.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusRelated diseasesRo particleAnti-Ro autoantibodiesAnti-Ro seraCell fractionRo antibodiesSystemic lupusLupus erythematosusPatient seraImmunological heterogeneityAutoantibodiesSpecific serumRo responseNonhuman cell linesSerumAntigenic determinantsAntibodiesCell linesInhibition assaysDiseaseEpitopesCompetitive inhibitionSuch extractsErythematosus
1988
Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins.
Gelpi C, Rodriguez-Sanchez JL, Martinez MA, Craft J, Hardin JA. Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins. The Journal Of Immunology 1988, 140: 4160-6. PMID: 3372998, DOI: 10.4049/jimmunol.140.12.4160.Peer-Reviewed Original ResearchConceptsHost diseaseChronic graftAutoimmune responseMixed connective tissue diseaseInduction of graftConnective tissue diseaseHuman rheumatic diseasesAnti-U1 RNPAntinuclear antibodiesMurine graftRheumatic diseasesRNP autoantibodiesTissue diseaseAutoantigenic epitopesLymphoid cellsJ strainAdditional seraGraftDiseaseMiceSerumAntibodiesAutoantibodiesMaximal levelsHuman serum